You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Brodalumab

Showing 26 - 50 of 57
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Psoriasis Vulgaris Trial in Germany (Brodalumab, Fumaric acid esters)

Completed
Has Results
  • Psoriasis Vulgaris
  • Brodalumab
  • Fumaric acid esters
  • Bad Bentheim, Germany
  • +29 more
Feb 10, 2020

Incident IMID in Patients Treated With Biologics and

Not yet recruiting
  • Inflammatory Disease
    • Paris, France
      Hôpital Saint-Antoine
    Jan 23, 2023

    Psoriasis Trial in Worldwide (210 mg brodalumab, 140 mg brodalumab, )

    Terminated
    Has Results
    • Psoriasis
    • 210 mg brodalumab
    • +2 more
    • Phoenix, Arizona
    • +77 more
    Dec 17, 2019

    Palmoplantar Pustulosis Trial in Obihiro, Sapporo (KHK4827, Placebo)

    Active, not recruiting
    • Palmoplantar Pustulosis
    • Obihiro, Hokkaido, Japan
    • +1 more
    Apr 4, 2022

    Hidradenitis Suppurativa Trial in Coral Gables (Brodalumab)

    Unknown status
    • Hidradenitis Suppurativa
    • Brodalumab
    • Coral Gables, Florida
      Florida Academic Centers Research and Education, LLC
    Apr 9, 2019

    Plaque Psoriasis Trial in Worldwide (210 mg brodalumab, 140 mg brodalumab, ustekinumab)

    Terminated
    Has Results
    • Plaque Psoriasis
    • 210 mg brodalumab
    • +3 more
    • Birmingham, Alabama
    • +156 more
    Dec 17, 2019

    Moderate to Severe Plaque Psoriasis Trial in Worldwide (210 mg brodalumab, 140 mg brodalumab, ustekinumab)

    Terminated
    Has Results
    • Moderate to Severe Plaque Psoriasis
    • 210 mg brodalumab
    • +3 more
    • Birmingham, Alabama
    • +153 more
    Jan 3, 2020

    Systemic Sclerosis Trial in Bunkyo-ku (KHK4827)

    Active, not recruiting
    • Systemic Sclerosis
    • Bunkyo-ku, Tokyo, Japan
      The University of Tokyo Hospital
    Jun 28, 2021

    Moderate to Severe Systemic Sclerosis Trial in Japan (KHK4827, Placebo)

    Active, not recruiting
    • Moderate to Severe Systemic Sclerosis
    • Nagoya, Aichi, Japan
    • +5 more
    Jun 28, 2021

    Patients Treated With Secukinumab for Moderate to Severe Plaque

    Completed
    • Plaque Psoriasis
    • Bangkok, Thailand
      Novartis Investigative Site
    Dec 6, 2022

    Among Psoriasis Patients Treated With Cosentyx (Secukinumab)

    Completed
    • Psoriasis
    • East Hanover, New Jersey
      Novartis Investigative Site
    Jun 29, 2022

    Moderate to Severe Plaque Psoriasis Trial in Seoul (KHK4827, Placebo)

    Completed
    • Moderate to Severe Plaque Psoriasis
    • Seoul, Korea, Republic of
      Korea, Republic of
    Sep 9, 2018

    Axial Spondyloarthritis Trial in Japan, Korea, Republic of, Taiwan (KHK4827, Placebo)

    Completed
    • Axial Spondyloarthritis
    • Aichi, Japan
    • +47 more
    Mar 2, 2020

    Asthma Trial in Worldwide (AMG 827, Placebo)

    Completed
    Has Results
    • Asthma
    • AMG 827
    • Placebo
    • Encinitas, California
    • +48 more
    Oct 29, 2021

    Occurrence ofClinical RElapse and Gut MIcrobiota

    Not yet recruiting
    • Psoriasis
    • Microbial Colonization
    • Fecal sampling
    • Blood sampling
    • (no location specified)
    Sep 20, 2023

    Psoriasis Trial in Worldwide

    Recruiting
    • Psoriasis
      • Birmingham, Alabama
      • +446 more
      Jan 31, 2023

      Psoriatic Arthritis Trial in Canada, United States (AMG 827 140, Placebo, AMG 827 280)

      Terminated
      Has Results
      • Psoriatic Arthritis
      • AMG 827 140
      • +3 more
      • Peoria, Arizona
      • +30 more
      Aug 19, 2020

      Psoriasis Vulgaris, Psoriatic Arthritis, Pustular; Psoriasis, Palmaris Et Plantaris Trial in Chiyoda-ku (KHK4827 140mg SC,

      Completed
      • Psoriasis Vulgaris
      • +3 more
      • KHK4827 140mg SC
      • KHK4827 210mg SC
      • Chiyoda-ku, Tokyo, Japan
        For additional information regarding investigative sites for thi
      Nov 13, 2019

      Rheumatoid Arthritis Trial in Worldwide (AMG 827)

      Terminated
      Has Results
      • Rheumatoid Arthritis
      • AMG 827
      • Scottsdale, Arizona
      • +43 more
      Feb 3, 2022

      Psoriasis Trial (70 mg SC, 210 mg SC, 140 mg SC)

      Completed
      Has Results
      • Psoriasis
      • 70 mg SC
      • +4 more
      • (no location specified)
      Jun 21, 2019

      Psoriasis Trial in Worldwide (AMG 827)

      Terminated
      Has Results
      • Psoriasis
      • AMG 827
      • Newnan, Georgia
      • +20 more
      Jul 17, 2019

      Psoriasis Trial in United States (Brodalumab)

      Completed
      Has Results
      • Psoriasis
      • Brodalumab
      • Glendale, California
      • +5 more
      Apr 6, 2017

      Psoriasis Trial in Australia, New Zealand, United States (Brodalumab)

      Completed
      Has Results
      • Psoriasis
      • Brodalumab
      • Anaheim, California
      • +9 more
      Apr 7, 2017

      Psoriatic Arthritis Trial in Worldwide (210 mg brodalumab, 140 mg brodalumab, Placebo)

      Terminated
      Has Results
      • Psoriatic Arthritis
      • 210 mg brodalumab
      • +2 more
      • Huntsville, Alabama
      • +151 more
      Apr 7, 2017

      Psoriasis Trial in San Diego (210mg Brodalumab, 140mg Brodalumab, Ustekinumab)

      Terminated
      • Psoriasis
      • 210mg Brodalumab
      • +3 more
      • San Diego, California
        MedDerm Associates
      May 25, 2016